Simultaneous determination of hydrocodone and hydromorphone in human plasma by liquid chromatography with tandem mass spectrometric detection

• Published in: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Analytical technologies in the biomedical and life sciences, 2002-03, Vol.769 (1), p.55-64
• Main Authors: Chen, Yu-Luan, Hanson, Glenn D, Jiang, Xiangyu, Naidong, Weng
• Format: Article
• Language: English
• Subjects: Automation; Calibration; Chromatography, Liquid - methods; Humans; Hydrocodone; Hydrocodone - blood; Hydromorphone; Hydromorphone - blood; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization - methods
• ISSN: 1570-0232; 1873-376X
• DOI: 10.1016/S1570-0232(01)00616-X

A rapid, sensitive and specific liquid chromatography–tandem mass spectrometry (LC–MS–MS) method has been developed and validated for the simultaneous analysis of hydrocodone (HYC) and its metabolite hydromorphone (HYM) in human plasma. A robotic liquid handler and a 96-channel liquid handling workstation were used to aliquot samples, to add internal standard (I.S.), and to extract analytes of interest. A 96-well mixed-mode solid-phase cartridge plate was used to extract the analytes and I.S. The chromatographic separation was on a silica column (50×3 mm, 5-μm) with a mobile phase consisting of acetonitrile, water and trifluoroacetic acid (TFA) (92:8:0.01, v/v). The run time for each injection was 2.5 min with the retention times of approximately 2.1 and 2.2 min for HYC and HYM, respectively. The tandem mass spectrometric detection was by monitoring singly charged precursor→product ion transition 300→199 ( m/z) for HYC, and 286→185 ( m/z) for HYM. The validated calibration curve range was 0.100–100 ng/ml, based on a plasma volume of 0.3 ml. The correlation coefficients were greater than or equal to 0.9996 for both HYC and HYM. The low limit of quantitation (LLOQ) was 0.100 ng/ml for both HYC and HYM with signal-to-noise ratio ( S/N) of 50 and 10, respectively. The deuterated analytes, used as internal standards, were monitored at mass transitions 303→199 ( m/z) for HYC- d 3 and 289→185 ( m/z) for HYM- d 3. The inter-day ( n=17) precision of the quality control (QC) samples were ≤3.5% RSD (relative standard deviation) for HYC and ≤4.7% RSD for HYM, respectively. The inter-day accuracy of the QC samples were ≤2.1% RE (relative error) for HYC and ≤1.8% RE for HYM. The intra-day ( n=6) precision and accuracy of the QC samples were ≤2.6% RSD and ≤3.0% RE for HYC, and ≤4.7% RSD and ≤2.4% RE for HYM. There was no significant deviation from the nominal values after a 5-fold dilution of high concentration QC samples by blank matrix. The QC samples were stable when kept at room temperature for 24-h or experienced three freeze–thaw cycles. The extraction recoveries were 86% for HYC and 78% for HYM. No detectable carryover was observed when a blank sample was injected immediately after a 2500 ng/ml sample that was 25-fold more concentrated than the upper limit of quantitation (ULOQ).